Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma

Celyvir (autologous mesenchymal cells -MSCs- that carry an oncolytic adenovirus) is a new therapeutic strategy for metastatic tumors developed by our research group over the last decade. There are limitations for studying the immune effects of human oncolytic adenoviruses in murine models since thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco-Luzón, Lidia, González-Murillo, África, Alcántara-Sánchez, Cristina, García-García, Lorena, Tabasi, Maryam, Huertas, Ana Luis, Chesler, Louis, Ramírez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996901/
https://www.ncbi.nlm.nih.gov/pubmed/32064039
http://dx.doi.org/10.18632/oncotarget.27401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996901/
https://www.ncbi.nlm.nih.gov/pubmed/32064039
http://dx.doi.org/10.18632/oncotarget.27401

Ejemplares similares